Seymour L - Search Results

1

8th international conference on oncolytic virus therapeutics.

Guinn BA, Braidwood L, Parker A, Peng KW, Seymour L. Guinn BA, et al. Among authors: seymour l. Hum Gene Ther. 2014 Dec;25(12):1062-84. doi: 10.1089/hum.2014.118. Hum Gene Ther. 2014. PMID: 25274574

2

Laterally stabilized complexes of DNA with linear reducible polycations: strategy for triggered intracellular activation of DNA delivery vectors.

Oupický D, Parker AL, Seymour LW. Oupický D, et al. Among authors: seymour lw. J Am Chem Soc. 2002 Jan 9;124(1):8-9. doi: 10.1021/ja016440n. J Am Chem Soc. 2002. PMID: 11772047

3

Methodologies for monitoring nanoparticle formation by self-assembly of DNA with poly(l-lysine).

Parker AL, Oupicky D, Dash PR, Seymour LW. Parker AL, et al. Among authors: seymour lw. Anal Biochem. 2002 Mar 1;302(1):75-80. doi: 10.1006/abio.2001.5507. Anal Biochem. 2002. PMID: 11846378

4

Identification of FGF receptor-binding peptides for cancer gene therapy.

Maruta F, Parker AL, Fisher KD, Hallissey MT, Ismail T, Rowlands DC, Chandler LA, Kerr DJ, Seymour LW. Maruta F, et al. Among authors: seymour lw. Cancer Gene Ther. 2002 Jun;9(6):543-52. doi: 10.1038/sj.cgt.7700470. Cancer Gene Ther. 2002. PMID: 12032665

5

Comparison of molecular strategies for breast cancer virotherapy using oncolytic adenovirus.

Bazan-Peregrino M, Carlisle RC, Hernandez-Alcoceba R, Iggo R, Homicsko K, Fisher KD, Halldén G, Mautner V, Shen Y, Seymour LW. Bazan-Peregrino M, et al. Among authors: seymour lw. Hum Gene Ther. 2008 Sep;19(9):873-86. doi: 10.1089/hum.2008.047. Hum Gene Ther. 2008. PMID: 18710328

6

Oncolytic virotherapy: combining first-rate science with an unmet clinical need.

Seymour LW. Seymour LW. Hum Gene Ther. 2011 Apr;22(4):387-8. doi: 10.1089/hum.2011.3220. Hum Gene Ther. 2011. PMID: 21486159 No abstract available.

7

Adenovirus: teaching an old dog new tricks.

Seymour LW, Fisher KD. Seymour LW, et al. Hum Gene Ther. 2011 Sep;22(9):1041-2. doi: 10.1089/hum.2011.2517. Hum Gene Ther. 2011. PMID: 21932993 No abstract available.

8

Activity of a group B oncolytic adenovirus (ColoAd1) in whole human blood.

Di Y, Seymour L, Fisher K. Di Y, et al. Among authors: seymour l. Gene Ther. 2014 Apr;21(4):440-3. doi: 10.1038/gt.2014.2. Epub 2014 Feb 20. Gene Ther. 2014. PMID: 24553347

9

Tissue-specific attenuation of oncolytic sindbis virus without compromised genetic stability.

Kueberuwa G, Cawood R, Tedcastle A, Seymour LW. Kueberuwa G, et al. Hum Gene Ther Methods. 2014 Apr;25(2):154-65. doi: 10.1089/hgtb.2013.202. Hum Gene Ther Methods. 2014. PMID: 24568203

10

Improved in vitro human tumor models for cancer gene therapy.

Jakeman PG, Hills TE, Tedcastle AB, Di Y, Fisher KD, Seymour LW. Jakeman PG, et al. Hum Gene Ther. 2015 May;26(5):249-56. doi: 10.1089/hum.2015.028. Epub 2015 Apr 20. Hum Gene Ther. 2015. PMID: 25808057 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

547 results

Search Page